These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 17447527

  • 1. [Development of molecular target based-therapy for prion diseases].
    Sakasegawa Y, Doh-ura K.
    Brain Nerve; 2007 Apr; 59(4):405-14. PubMed ID: 17447527
    [Abstract] [Full Text] [Related]

  • 2. Transmissible spongiform encephalopathies.
    Liemann S, Glockshuber R.
    Biochem Biophys Res Commun; 1998 Sep 18; 250(2):187-93. PubMed ID: 9753605
    [Abstract] [Full Text] [Related]

  • 3. [Comments on present-day spread and epidemiology of BSE and prion diseases].
    Bodemer W, Kaup FJ.
    Gesundheitswesen; 2004 Feb 18; 66 Suppl 1():S21-5. PubMed ID: 14770333
    [Abstract] [Full Text] [Related]

  • 4. BSE: can we predict the future?
    Plum J.
    Bull Mem Acad R Med Belg; 1997 Feb 18; 152(6):264-73. PubMed ID: 9581370
    [Abstract] [Full Text] [Related]

  • 5. [Prion biology: update].
    Weber EL.
    Rev Argent Microbiol; 1999 Feb 18; 31(4):205-18. PubMed ID: 10615684
    [Abstract] [Full Text] [Related]

  • 6. [Basic research on BSE transmission to people].
    Bodemer W, Kaup FJ.
    Dtsch Tierarztl Wochenschr; 2002 Aug 18; 109(8):338-41. PubMed ID: 12224460
    [Abstract] [Full Text] [Related]

  • 7. The highways and byways of prion protein trafficking.
    Campana V, Sarnataro D, Zurzolo C.
    Trends Cell Biol; 2005 Feb 18; 15(2):102-11. PubMed ID: 15695097
    [Abstract] [Full Text] [Related]

  • 8. Role of the 37 kDa laminin receptor precursor in the life cycle of prions.
    Rieger R, Lasmézas CI, Weiss S.
    Transfus Clin Biol; 1999 Feb 18; 6(1):7-16. PubMed ID: 10188208
    [Abstract] [Full Text] [Related]

  • 9. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models].
    Kretzschmar H.
    Wien Med Wochenschr; 1998 Feb 18; 148(4):67-73. PubMed ID: 9611345
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biology and genetics of prion diseases.
    Prusiner SB.
    Annu Rev Microbiol; 1994 Feb 18; 48():655-86. PubMed ID: 7826022
    [Abstract] [Full Text] [Related]

  • 12. [Prions as the driving force in transmissible spongiform encephalopathies].
    Glatzel M, Gottwein J, Aguzzi A.
    Schweiz Arch Tierheilkd; 2002 Dec 18; 144(12):633-8. PubMed ID: 12585203
    [Abstract] [Full Text] [Related]

  • 13. [Spongiform encephalopathies in animals and humans].
    Jovanović M.
    Med Pregl; 1998 Dec 18; 51 Suppl 1():35-42. PubMed ID: 9769654
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Unconventional transmissible agents and prion protein: is something still missing?].
    Laplanche JL.
    Ann Biol Clin (Paris); 1997 Dec 18; 55(5):395-407. PubMed ID: 9347006
    [Abstract] [Full Text] [Related]

  • 17. Prion diseases: from molecular biology to intervention strategies.
    Nunziante M, Gilch S, Schätzl HM.
    Chembiochem; 2003 Dec 05; 4(12):1268-84. PubMed ID: 14661267
    [Abstract] [Full Text] [Related]

  • 18. A novel erythroid-specific marker of transmissible spongiform encephalopathies.
    Miele G, Manson J, Clinton M.
    Nat Med; 2001 Mar 05; 7(3):361-4. PubMed ID: 11231637
    [Abstract] [Full Text] [Related]

  • 19. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK, Jones EM, Apetri AC.
    Acc Chem Res; 2006 Sep 05; 39(9):654-62. PubMed ID: 16981682
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.